&nbsp;

Oct 2023

Drug

octreotide

Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)

Quick Link(s):

Aug 2016

Drug

Kadcyla trastuzumab emtansine

Other Name(s): Kadcyla®

Quick Link(s):

Aug 2023

Drug

osimertinib

Other Name(s): Tagrisso®

Quick Link(s):

Jan 2024

Regimen

OCTR

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI),

Lung,

Neuroendocrine (Lung)

Intent: Palliative

Funding:

ODB - General Benefit

octreotide

, Collapse Show fewer tags

Drugs Used:

octreotide

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

KADC

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab Emtansine - Unresectable Locally Advanced or Metastatic Breast Cancer

Kadcyla trastuzumab emtansine

Drugs Used:

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Aug 2023

Regimen

OXALRALT

Cancer Type:

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Small bowel and appendix

Intent: Adjuvant, Palliative

Funding:

New Drug Funding Program

Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Metastatic Esophageal, Gastroesophageal Junction, or Gastric Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Colorectal, Small Bowel, or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Esophageal, Gastroesophageal Junction, or Gastric Cancer